期刊
BLOOD
卷 110, 期 6, 页码 1970-1981出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2006-09-044776
关键词
-
类别
资金
- NIAID NIH HHS [R01 AI054128, R56 AI055677, AI55677, AI54128, R01 AI055677] Funding Source: Medline
CpG-DNA or its synthetic analog CpGODN activates innate immunity through Toll-like receptor 9 (TLR9). However, the mechanism of TLR9 activation by CpGDNA remains elusive. Here we have identified HMGB1 as a CpG-ODN-binding protein. HMGB1 interacts and preassociates with TLR9 in the endoplasmic reticulum-Golgi intermediate compartment (ERGIC), and hastens TLR9's redistribution to early endosomes in response to CpG.. ODN. CpG-ODN stimulates macrophages; and dendritic cells to secrete HMGB1; in turn, extracellular HMGB1 accelerates; the delivery of CpG-ODNs to its receptor., leading to a TLR9-dependent augmentation of IL-6, IL-12, and TNF alpha secretion.. Loss of HMGB1 leads to a defect in the IL-6, IL-12, TNFa, and iNOS response to CpG-ODN. However, lack of intracellular TLR9-associated HMGB1 can be compensated by extracellular HMGB1. Thus, the DNA-binding protein HMGB1 shuttles in and out of immune cells and regulates inflammatory responses to CpG-DNA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据